2168561-26-8
2168561-26-8
Chemical Structure
Manelimab
Synonym(s): BCD-135
- CAS No.: 2168561-26-8
- Formula:N/A
- Molecular Weight:N/A
IUPAC Name: 4-bromo-2-nitro-6-(trifluoromethyl)phenol
SMILES: [Manelimab]
Biological Activity: Manelimab (BCD-135) is a monoclonal antibody targeting PD-L1 with PD-L1 inhibitory activity. Manelimab blocks the interaction between PD-L1 and PD-1 to abrogate the immunosuppressive signals of T cells in the tumor microenvironment. Manelimab is applicable for tumor-related research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Manelimab | Manelimab (BCD-135) is a monoclonal antibody targeting PD-L1 with PD-L1 inhibitory activity. Manelimab blocks the interaction between PD-L1 and PD-1 to abrogate the immunosuppressive signals of T cells in the tumor microenvironment. Manelimab is applicable for tumor-related research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
